Virtual Reality Telerehabilitation for Postural Instability in Parkinson’s Disease: A Multicenter, Single-Blind, Randomized, Controlled Trial
Table 5
Descriptive and inferential statistics for clinical outcome measures.
Outcomes
Before T0
After T1
Follow-up T2
Intervention phase
Repeated-measures ANOVA
Post hoc analysis
Mean (SD)
Mean (SD)
Mean (SD)
Between-group difference (95% CI) mean (LB, UB)
Group
Time
Time × group
Between-group differences
Within-group differences
TeleWii
SIBT
TeleWii
SIBT
TeleWii
SIBT
TeleWii
SIBT
After
FU
After
FU
After
FU
After
FU
Primary outcome
BBS (0–56)
48.63 (6.31)
45.61 (7.97)
52.37 (3.29)
49.82 (5.70)
51.84 (4.53)
49.66 (6.59)
2.54 (0.41, 4.67)
2.18 (−0.40, 4.77)
0.0
<0.00
n.s.
0.0
n.s
<0.00
0.00
<0.00
<0.00
Secondary outcomes
ABC (0–100)
70.31 (18.17)
64.12 (21.37)
79.62 (14.16)
72.52 (21.20)
76.34 (15.98)
71.73 (19.92)
7.10 (−1.16, 15.36)
4.61 (−3.65, 12.87)
n.s.
<0.00
n.s.
n.s.
n.s.
<0.00
<0.00
<0.00
<0.00
10-MW (m/s)
1.59 (0.49)
1.46 (0.42)
1.62 (0.43)
1.60 (0.44)
1.57 (0.42)
1.52 (0.37)
0.35 (-0.16, 0.23)
0.04 (−0.14, 0.22)
n.s.
0.0
n.s.
n.s.
n.s.
n.s
n.s.
0.035
n.s
DGI
20.39 (2.56)
19.34 (2.49)
21.24 (2.56)
21.18 (2.15)
21.32 (2.81)
21.05 (2.54)
0.53 (−1.03, 1.13)
0.26 (−0.96, 1.49)
n.s.
<0.00
0.0
n.s.
n.s.
0.00
0.00
<0.00
<0.00
Falls (number)
0.58 (1.44)
1.84 (5.30)
0.38 (1.33)
0.61 (1.81)
0.29 (0.94)
0.81 (3.31)
−0.23 (−0.95, 0.49)
−0.52 (−1.65, 0.60)
n.s.
n.s
n.s
n.s.
n.s.
n.s.
0.03
n.s.
n.s.
PDQ-8
30.72 (15.54)
30.53 (16.04)
24.16 (14.78)
24.21 (15.85)
25,82 (14.89)
23.91 (13.20)
−0.05 (−7.06, 6.95)
1.90 (−4.52, 8.34)
n.s.
<0.00
n.s.
n.s.
n.s.
<0.00
0.0
0.01
0.00
Before: pretreatment; after: posttreatment; FU: one-month follow-up; SD: standard deviation; TeleWii: telerehabilitation using virtual reality-based training; SIBT sensory integration balance training; : value; BBS: Berg Balance Scale (higher score indicates better performance); falls, number of falls in the previous month; ABC: Activities Balance Confidence scale (higher score indicates better performance); 10-MWT, 10-Meter Walking Test; DGI, Dynamic Gait Index; PDQ-8, Parkinson’s Disease Quality of Life questionnaire; CI: confidence interval; LB: lower bound; UB: upper bound; ANOVA: analysis of variance; significant. For repeated-measures ANOVA, value is significant if <0.05. For post hoc analysis, is significant if <0.025.